| Issue |
Section |
Title |
File |
| Vol 81, No 7 (2009) |
Editorial |
Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in subleukemic myelosis and congenital immunodeficiency |
|
| Vol 90, No 8 (2018) |
Editorial |
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease |
(Rus)
|
| Vol 90, No 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Differential diagnosis of ascites in internal medicine: clinical case |
(Rus)
|
| Vol 91, No 2 (2019) |
Editorial |
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study |
(Rus)
(Eng)
|
| Vol 91, No 2 (2019) |
Editorial |
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy |
(Rus)
|
| Vol 92, No 3 (2020) |
Editorial |
Changes in gut microbiota with bronchial asthma |
(Rus)
|
| Vol 92, No 4 (2020) |
Original articles |
Rebamipide using in gastroesophageal reflux disease treatment |
(Rus)
|
| Vol 94, No 2 (2022) |
Consensuns |
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities |
(Rus)
|
| Vol 93, No 11 (2021) |
Original articles |
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis |
(Rus)
|
| Vol 97, No 8 (2025): Treatment issues |
Original articles |
Clinical and morphological features and functional parameters in patients with gastroesophageal reflux disease and Barrett's esophagus |
(Rus)
|
